ACH Accendra Health, Inc. Common Stock
NYSE · Health Care · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Jan 24, 2024ACH Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
ACH Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
| Data ex | Desdobramento | Tipo |
|---|---|---|
| 1 de Abril de 2010 | 3-for-2 | Para frente |
| 9 de Junho de 1994 | 3-for-2 | Para frente |
| 23 de Março de 1993 | 3-for-2 | Para frente |
| 17 de Julho de 1991 | 3-for-2 | Para frente |
| 1 de Junho de 1988 | 3-for-2 | Para frente |
| 3 de Setembro de 1985 | 3-for-2 | Para frente |
| 1 de Novembro de 1982 | 2-for-1 | Para frente |
Sobre Accendra Health, Inc. Common Stock Visão geral da empresa da Wikipedia
Accendra Health is a global healthcare company. It employs over 20,000 people in 70 countries. A Fortune 500 company, it was founded in 1882 in Richmond, Virginia, where it remains headquartered. The company has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. President and CEO Ed Pesicka joined Owens & Minor in March 2019.
History
Owens & Minor originally opened as a pharmacy company in downtown Richmond, Virginia in 1882, inside a historic building which still stands today. The company continued this business for over half a century until, in 1954, Gil Minor, Jr. bought out Bodeker Drug Company, a smaller operation in the same industry, changing the company name to Owens, Minor & Bodeker.
In 1966, the company acquired Virginia A&J Hospital Supply, adding medical and surgical distribution to its portfolio. By 1970, OMB had opened Cardinal Drug Centers, merchandising its products to independent drug companies, stocking shops with over 25,000 items within two years. Around this time, disposable items were distributed to hospitals for various medical procedures. G. Gilmer Minor III, a direct relation to the founder, became CEO in 1984. By 1988, Owens & Minor began trading on the New York Stock Exchange under the ticker OMI. It was around this time that revenues earned the company a Fortune 500 ranking.
By 1999, the company had refocused toward medical supply chain management. Throughout the 2000s, Owens & Minor acquired various medical distributors across the United States, notably the hospital distributor McKesson Medical-Surgical Inc., a business unit of McKesson, for $152.1 million, on September 30, 2006. In 2012, it entered the European market, opening offices in Spain, France, Germany, Poland, and the Czech Republic after the acquisition of Movianto Group. In 2014, the corporation acquired ArcRoyal, a privately held medical kit company based in Dublin, Ireland.
In 2018, it acquired Halyard Health’s Surgical & Infection Prevention business for $710 million, the largest acquisition in the company’s history. Halyard is a manufacturer of sterilization wrap, facial protection products, exam gloves, protective apparel, surgical drapes and surgical gowns.
In May 2022, Owens & Minor stated that 45 percent of the items it offers are in some way supply-constrained due to the 2021–2022 global supply chain crisis. The following month, the company broke ground in Morgantown, West Virginia for a 350,000 square-foot medical supplies and logistics center, to be completed in late 2023, which will include dedicated acute care medical distribution facilities and clinical supply capabilities.
In July 2024, the company announced it had agreed to acquire medical equipment firm Rotech Healthcare for $1.36 billion. However, the companies terminated the deal in June 2025, citing regulatory hurtles. As a result, the Owens & Minor paid Rotech an $80 million termination payment.
Personnel
On March 7, 2019 Edward A. Pesicka became president and CEO, then also joined the company's Board of Directors. Pesicka was a former executive at Thermo Fisher Scientific.
Richmond, Virginia center
In the fourth quarter of 2017, Owens & Minor opened a second office and customer service center in downtown Richmond, Virginia as part of a business rebranding strategy. The corporation also continued to work from its various offices across the United States.
Movianto
In 2018, the company’s Movianto subsidiary won a contract estimated at £10.5m a year to warehouse and distribute the UK government’s stock of emergency personal protection equipment (PPE) which had previously been managed by DHL.
Following a dispute over payment of rent, Movianto gained a UK High Court injunction in March 2019 to stop Industrial North West LLP, owner of the rented industrial property, from locking the gates and thereby preventing the company from conducting its business.
In 2020, Movianto was criticised as causing delays to the distribution of the UK government’s stockpile of PPE. Following news of shortages in hospitals, the British army was sent to Movianto’s warehouse to assist in the rapid deployment of PPE, with the Department of Health and Social Care contradicting the allegation. An investigation did establish, however, that Movianto had previously stored the equipment in a smoke-damaged warehouse that was found to contain asbestos.
On January 16, 2020, Owens & Minor announced its intention to sell its European logistics business, Movianto, to EHDH Holding Group (EHDH), a privately held French company providing healthcare logistics services to European markets, with the sale completed June 18, 2020.
Divest of P&HS - Rebrand Accendra Health, Inc.
On December 31 2025, Owens & Minor, Inc. announced the completion of the sale of its Products & Healthcare Services (P&HS) segment and the Owens & Minor brand to Platinum Equity and is renaming the publicly traded parent company Accendra Health, Inc.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Ainda não há dados fundamentais suficientes para calcular este grupo de proporções.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Ainda não há dados fundamentais suficientes para calcular este grupo de proporções.
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Ainda não há dados fundamentais suficientes para calcular este grupo de proporções.
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Ainda não há dados fundamentais suficientes para calcular este grupo de proporções.
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Ainda não há dados fundamentais suficientes para calcular este grupo de proporções.
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
| Data ex | Valor | Moeda | Rendimento |
|---|---|---|---|
| Dez 14, 2021 | $0,00 | USD | ≈0.03% |
| Set 14, 2021 | $0,00 | USD | ≈0.03% |
| Jun 14, 2021 | $0,00 | USD | ≈0.03% |
| Mar 12, 2021 | $0,00 | USD | ≈0.03% |
| Dez 14, 2020 | $0,00 | USD | ≈0.04% |
| Set 14, 2020 | $0,00 | USD | ≈0.08% |
| Jun 12, 2020 | $0,00 | USD | ≈0.16% |
| Mar 13, 2020 | $0,00 | USD | ≈0.28% |
| Dez 13, 2019 | $0,00 | USD | ≈1.6% |
| Set 13, 2019 | $0,00 | USD | ≈5.5% |
| Jun 13, 2019 | $0,00 | USD | ≈20.8% |
| Mar 14, 2019 | $0,00 | USD | ≈12.6% |
| Dez 14, 2018 | $0,08 | USD | ≈13.2% |
| Set 14, 2018 | $0,26 | USD | ≈6.4% |
| Jun 14, 2018 | $0,26 | USD | ≈6.4% |
| Mar 14, 2018 | $0,26 | USD | ≈6.2% |
| Dez 14, 2017 | $0,26 | USD | ≈5.5% |
| Set 14, 2017 | $0,26 | USD | ≈3.6% |
| Jun 13, 2017 | $0,26 | USD | ≈3.2% |
| Mar 13, 2017 | $0,26 | USD | ≈2.9% |
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Ago 10, 2026 | $-0.19 | $-0.09 | -113.0% |
| 31 de Março de 2026 | $-0.04 | $-0.10 | 60.9% | |
| 31 de Dezembro de 2025 | $0.21 | $0.22 | -5.8% | |
| 30 de Setembro de 2025 | $0.25 | $0.23 | 6.7% | |
| 30 de Junho de 2025 | $0.26 | $0.28 | -6.3% | |
| 31 de Março de 2025 | $0.23 | $0.20 | 16.6% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $290.99B | $298.89B | $203.99B | $190.22B | $180.35B | $181.02B | $144.85B | |
| Cost of Revenue | $259.70B | $264.17B | $188.52B | $179.28B | $167.11B | $166.29B | $133.70B | |
| Gross Profit | $31.28B | $34.72B | $15.47B | $10.93B | $13.24B | $14.73B | $11.15B | |
| R&D Expense | $4.81B | $2.42B | $1.47B | $941M | $627M | $498M | $169M | |
| SG&A Expense | $6.01B | $6.33B | $5.06B | $3.97B | $3.98B | $4.55B | · | |
| Operating Income | $16.39B | $18.67B | $7.60B | $6.21B | $6.82B | · | · | |
| Interest Expense | $3.83B | $4.51B | $4.99B | $4.38B | $4.69B | $4.83B | $4.76B | |
| Interest Income | $477M | $311M | $266M | $261M | $492M | $707M | $816M | |
| Pretax Income | $13.21B | $14.19B | $2.89B | $1.87B | $2.27B | $3.05B | $1.62B | |
| Income Tax | $2.37B | $2.87B | $641M | $632M | $826M | $644M | $404M | |
| Net Income | $4.19B | $5.76B | $862M | $596M | $709M | $1.41B | $366M | |
| EPS (Basic) | $0.24 | $0.33 | $0.03 | $0.02 | $0.03 | $0.09 | $0.02 | |
| EPS (Diluted) | $0.24 | $0.33 | $0.03 | $0.02 | · | · | · | |
| Shares (Basic) | 17,022,673 | 17,022,673 | 17,022,673 | 17,022,673 | 16,842,714 | 14,903,798,236 | 14,903,798,236 | |
| Shares (Diluted) | · | · | · | 17,022,672,951 | 16,842,713,738 | 14,903,798,236 | 14,903,798,236 | |
| EBITDA | $16.39B | $13.41B | $6.02B | · | · | · | · |
Balanço Patrimonial
| Métrica | Tendência | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16.82B | $19.68B | $9.67B | $7.78B | $19.13B | $27.85B | $23.85B | |
| Receivables | $5.87B | $7.11B | $9.31B | $7.42B | $8.10B | · | · | |
| Inventory | $24.71B | $21.64B | $19.86B | $19.52B | $20.46B | $20.55B | $17.93B | |
| Current Assets | $54.54B | $54.11B | $46.27B | $48.70B | $58.90B | $68.64B | $66.49B | |
| PP&E (Net) | $109.28B | $121.38B | $130.93B | $103.49B | $99.61B | $95.73B | $90.37B | |
| Goodwill | $3.50B | $3.51B | $3.51B | · | · | · | · | |
| Total Assets | $212.35B | $224.86B | $195.04B | $203.14B | $200.96B | $199.82B | $190.51B | |
| Current Liabilities | $62.37B | $61.92B | $62.63B | $69.20B | $74.84B | $90.34B | $83.18B | |
| Total Liabilities | $124.59B | $135.17B | $123.74B | $132.38B | $133.30B | $134.07B | $134.72B | |
| Retained Earnings | $10.09B | $6.81B | $-1.98B | $-2.21B | $-2.86B | $-3.33B | $-4.64B | |
| Stockholders' Equity | $54.40B | $60.48B | $54.45B | $54.67B | $52.42B | $39.69B | $38.17B |
Fluxo de Caixa
| Métrica | Tendência | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $8.06B | $7.06B | $7.00B | |
| Operating Cash Flow | $27.75B | $35.16B | $19.42B | $12.51B | $13.02B | $13.21B | $11.61B | |
| CapEx | $4.42B | $3.19B | $10.33B | $9.05B | $6.75B | $8.89B | $6.33B | |
| Investing Cash Flow | $-3.42B | $-1.67B | $-3.31B | $-13.40B | $-5.53B | $-5.60B | $-2.63B | |
| Dividends Paid | $2.51B | $579M | $423M | $223M | $328M | $309M | $20M | |
| Financing Cash Flow | $-27.04B | $-23.41B | $-18.23B | $-10.47B | $-16.28B | $-3.39B | $-6.11B | |
| Free Cash Flow | $23.33B | $26.19B | $9.84B | $3.58B | · | · | · | |
| Levered FCF | $20.19B | $23.50B | $7.02B | $501M | · | · | · |
Lucratividade
| Métrica | Tendência | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 10.8% | 9.8% | 7.2% | 6.4% | · | · | · | |
| Operating Margin | 5.6% | 5.0% | 3.2% | · | · | · | · | |
| Net Margin | 1.4% | 1.9% | 0.40% | 0.45% | · | · | · | |
| Pretax Margin | 4.5% | 3.8% | 1.2% | 1.1% | · | · | · | |
| EBITDA Margin | 5.6% | 5.0% | 3.2% | · | · | · | · | |
| ROA | 1.9% | 2.6% | 0.37% | 0.42% | · | · | · | |
| ROE | 7.3% | 9.1% | 1.4% | 1.6% | · | · | · | |
| ROIC | 24.7% | 17.9% | 8.1% | · | · | · | · |
Liquidez e Solvência
| Métrica | Tendência | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.7 | 0.7 | · | · | · | |
| Quick Ratio | 0.4 | 0.5 | 0.3 | 0.2 | · | · | · | |
| Interest Coverage | 4.3 | 3.8 | 1.6 | · | · | · | · |
Eficiência
| Métrica | Tendência | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.3 | 1.4 | 0.9 | 0.9 | · | · | · | |
| Inventory Turnover | 11.2 | 12.6 | 8.8 | 8.9 | · | · | · | |
| Receivables Turnover | 44.8 | 33.3 | 22.3 | 24.5 | · | · | · |
Por Ação
| Métrica | Tendência | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue / Share | · | · | · | $11.17 | · | · | · | |
| Cash Flow / Share | · | · | · | $0.73 | · | · | · | |
| EPS (TTM) | $0.24 | $0.29 | $0.03 | $0.02 | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $290.99B | $269.75B | $185.99B | $190.22B | · | · | · | |
| Net Income TTM | $4.19B | $5.08B | $764M | $596M | · | · | · | |
| P/E | 81.7 | 152.1 | 901.7 | 235.0 | · | · | · | |
| Earnings Yield | 1.2% | 0.66% | 0.11% | 0.43% | · | · | · | |
| Payout Ratio | 60.0% | 9.1% | 48.1% | 26.2% | · | · | · | |
| Annual Payout | $2.51B | $461M | $356M | $223M | · | · | · |
Por Ação
| Métrica | Tendência | Q4 2022 | Q4 2021 | Q4 2019 | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (TTM) | · | $0.29 | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | Q4 2022 | Q4 2021 | Q4 2019 | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $269.75B | · | · | $144.85B | $123.67B | · | · | · | · | · | |
| Net Income TTM | · | $5.08B | · | · | $366M | $130M | · | · | · | · | · | |
| P/E | · | 152.1 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | · | 0.66% | · | · | · | · | · | · | · | · | · | |
| Annual Payout | · | $461M | · | · | $20M | $20M | · | · | · | · | · |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Receita | $290.99B | $298.89B | $203.99B | $190.22B | $180.35B |
| Margem Bruta % | 10.8% | 9.8% | 7.2% | 6.4% | · |
| Margem Operacional % | 5.6% | 5.0% | 3.2% | · | · |
| Lucro líquido | $4.19B | $5.76B | $862M | $596M | $709M |
| EPS Diluído | $0.24 | $0.33 | $0.03 | $0.02 | · |
| Métrica | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 0.9 | 0.9 | 0.7 | 0.7 | · |
| Índice de Liquidez Seca | 0.4 | 0.5 | 0.3 | 0.2 | · |
| Métrica | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $23.33B | $26.19B | $9.84B | $3.58B | · |
Investidores institucionais (13F) 161 declarantes · $236.6M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 22 (-7 vs trimestre anterior) | 21 (-25 vs trimestre anterior) | 47 (+8 vs trimestre anterior) | 45 (-7 vs trimestre anterior) | -61K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| Coliseum Capital Management, LLC | $44.804.760 | 13.100.807 | 18,94% | Ações |
| BlackRock, Inc. | $18.824.028 | 5.504.102 | 7,96% | Ações |
| VANGUARD GROUP INC | $17.691.199 | 6.318.285 | 7,48% | Ações |
| BANK OF AMERICA CORP /DE/ | $12.912.296 | 3.775.525 | 5,46% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $10.560.724 | 3.087.931 | 4,46% | Ações |
| D. E. Shaw & Co., Inc. | $10.538.412 | 3.081.407 | 4,45% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9.877.158 | 2.888.058 | 4,17% | Ações |
| Invenomic Capital Management LP | $9.618.661 | 2.812.474 | 4,07% | Ações |
| MARSHALL WACE, LLP | $8.832.423 | 2.582.579 | 3,73% | Ações |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $8.675.511 | 2.536.699 | 3,67% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6.945.870 | 2.030.956 | 2,94% | Ações |
| Dana Investment Advisors, Inc. | $6.650.556 | 1.944.607 | 2,81% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $6.408.062 | 1.873.127 | 2,71% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $5.609.358 | 1.640.163 | 2,37% | Ações |
| STATE STREET CORP | $5.475.974 | 1.601.162 | 2,31% | Ações |
| Connor, Clark & Lunn Investment Management Ltd. | $4.407.652 | 1.288.787 | 1,86% | Ações |
| AQR CAPITAL MANAGEMENT LLC | $3.650.249 | 1.067.324 | 1,54% | Ações |
| GOLDMAN SACHS GROUP INC | $2.923.176 | 854.730 | 1,24% | Ações |
| TWO SIGMA INVESTMENTS, LP | $2.457.441 | 718.550 | 1,04% | Ações |
| NORTHERN TRUST CORP | $1.989.770 | 581.804 | 0,84% | Ações |
| WOLVERINE ASSET MANAGEMENT LLC | $1.942.847 | 568.084 | 0,82% | Ações |
| TUDOR INVESTMENT CORP ET AL | $1.939.995 | 567.250 | 0,82% | Ações |
| JANE STREET GROUP, LLC | $1.833.462 | 536.100 | 0,77% | Opção de compra |
| Vanguard Global Advisers, LLC | $1.742.463 | 509.492 | 0,74% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $1.665.913 | 487.109 | 0,70% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.575.252 | 460.600 | 0,67% | Opção de compra |
| TWO SIGMA ADVISERS, LP | $1.518.922 | 542.472 | 0,64% | Ações |
| BW Gestao de Investimentos Ltda. | $1.446.971 | 423.091 | 0,61% | Ações |
| CITADEL ADVISORS LLC | $1.321.919 | 386.526 | 0,56% | Ações |
| CITADEL ADVISORS LLC | $1.191.528 | 348.400 | 0,50% | Opção de compra |
| Nebula Research & Development LLC | $1.115.105 | 122.539 | 0,47% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $1.109.492 | 324.413 | 0,47% | Ações |
| MORGAN STANLEY | $1.052.342 | 307.701 | 0,44% | Ações |
| Linden Thomas Advisory Services, LLC | $932.501 | 272.661 | 0,39% | Ações |
| Bank of New York Mellon Corp | $917.257 | 268.204 | 0,39% | Ações |
| Nuveen, LLC | $803.515 | 234.946 | 0,34% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $794.692 | 232.366 | 0,34% | Ações |
| Kennondale Capital Management LLC | $772.544 | 225.890 | 0,33% | Ações |
| STRS OHIO | $716.148 | 209.400 | 0,30% | Ações |
| MILLENNIUM MANAGEMENT LLC | $690.902 | 202.018 | 0,29% | Ações |
| Cubist Systematic Strategies, LLC | $593.424 | 123.630 | 0,25% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $546.095 | 159.677 | 0,23% | Ações |
| WELLS FARGO & COMPANY/MN | $542.754 | 158.700 | 0,23% | Ações |
| XTX Topco Ltd | $503.725 | 147.288 | 0,21% | Ações |
| ARISTEIA CAPITAL, L.L.C. | $447.391 | 130.816 | 0,19% | Ações |
| Invesco Ltd. | $446.351 | 130.512 | 0,19% | Ações |
| Man Group plc | $436.009 | 127.488 | 0,18% | Ações |
| RAYMOND JAMES FINANCIAL INC | $408.047 | 119.312 | 0,17% | Ações |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $362.520 | 106.000 | 0,15% | Ações |
| Allspring Global Investments Holdings, LLC | $356.879 | 99.687 | 0,15% | Ações |
Participação em ETFs Detido por 18 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| VFVA · VANGUARD WELLINGTON FUND | 0,17% | 426.785 SH | 19 de Agosto de 2026 | Diário |
| QIDX · Spinnaker ETF Series | 0,11% | 14.310 NS | 31 de Julho de 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 62.833 SH | 19 de Agosto de 2026 | Diário |
| IWC · iShares Trust | 0,02% | 248.081 SH | 11 de Setembro de 2026 | Diário |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 414.904 SH | 19 de Agosto de 2026 | Diário |
| DFSV · Dimensional ETF Trust | 0,01% | 233.042 NS | 31 de Julho de 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 34.414 NS | 31 de Julho de 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,00% | 134.690 NS | 31 de Julho de 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 1.902.936 SH | 11 de Setembro de 2026 | Diário |
| PRF · Invesco Exchange-Traded Fund Trust | 0,00% | 96.796 SH | 1 de Outubro de 2026 | Diário |
| DFAS · Dimensional ETF Trust | 0,00% | 29.296 NS | 31 de Julho de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 105.616 SH | 8 de Setembro de 2026 | Diário |
| IWV · iShares Trust | 0,00% | 19.827 SH | 3 de Setembro de 2026 | Diário |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 833.270 SH | 19 de Agosto de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.185.973 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.453 SH | 19 de Agosto de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,00% | 184.892 SH | 19 de Agosto de 2026 | Diário |
| IWN · iShares Trust | · | 666.394 SH | 11 de Setembro de 2026 | Diário |
ACH Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
Preço-alvo de 12 meses
4 analistas · 2026-09-30Alvo médio $1.51 +199,4%
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.